Full Text View
Tabular View
No Study Results Posted
Related Studies
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis
This study has been completed.
Study NCT00076869   Information provided by Merck
First Received: February 5, 2004   Last Updated: May 17, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Aspergillosis
More general conditions related to this trial
Mycoses
Interventions listed in this trial
MK0991, caspofungin acetate
Comparator: amphotericin B
Additional drug interventions recognized in this trial
Abelcet
Amphotericin B
Caspofungin
Liposomal amphotericin B
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antifungal
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services